Relationship between the prevalence of anti-glutamic acid decarboxylase autoantibodies and duration of type 1 diabetes mellitus in Brazilian patients
The objective of the present study was to determine whether the duration of disease has any influence on the prevalence of glutamic acid decarboxylase autoantibodies (GADA) in Brazilian patients with type 1 diabetes (T1D) and variable disease duration. We evaluated 83 patients with T1D. All particip...
Main Authors: | M. Rodacki, L. Zajdenverg, M.S. Albernaz, M.R. Bencke-Gonçalves, A. Milech, J.E.P. Oliveira |
---|---|
Format: | Article |
Language: | English |
Published: |
Associação Brasileira de Divulgação Científica
2004-11-01
|
Series: | Brazilian Journal of Medical and Biological Research |
Subjects: | |
Online Access: | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2004001100008 |
Similar Items
-
Reducing glutamic acid decarboxylase in the dorsal dentate gyrus attenuates juvenile stress induced emotional and cognitive deficits
by: Kuldeep Tripathi, et al.
Published: (2021-11-01) -
Islet Cell Associated Autoantibodies and C-Peptide Levels in Patients with Diabetes and Symptoms of Gastroparesis
by: Elias S. Siraj, et al.
Published: (2018-02-01) -
GAD65 autoantibody characteristics in patients with co-occurring type 1 diabetes and epilepsy may help identify underlying epilepsy etiologies
by: Suvi Liimatainen, et al.
Published: (2018-04-01) -
The Role of GAD65 Autoantibody in Diabetes Mellitus and their First-Degree Relatives and Comparison with Healthy Persons
by: M Nakhjavani, et al.
Published: (2001-06-01) -
Limbic autoimmune encephalitis with antibodies to glutamate decarboxylase (GAD)
by: L. U. Ulukhanova, et al.
Published: (2020-06-01)